CIT Vs Apotex Research Pvt. Ltd. (Karnataka High Court)
Loss Filter Fails, Revenue Changes Tack: Karnataka HC Upholds Inclusion of Transfer Pricing Comparable
The Dispute: Why Was the Comparable Excluded?
The Karnataka High Court dismissed the Revenue’s appeal against the Tribunal’s direction to include Neeman Medical International (Asia) Ltd. as a comparable for determining the arm’s length price of transactions undertaken by Apotex Research Private Ltd.
The controversy turned on the actual reason for excluding the company. Before the Transfer Pricing Officer and the Tribunal, the objection concerned its alleged status as a consistently loss-making company. Before the High Court, the Revenue argued that the company was functionally dissimilar.
The Court found that functional dissimilarity had not been the basis of the earlier exclusion and that the Revenue could not identify any error in the Tribunal’s factual finding that Neeman was not consistently loss-making. Consequently, no substantial question of law arose.
Revenue Challenges the Tribunal’s Selection of Comparables
The appeal arose from the Bangalore Tribunal’s order dated 23 November 2012 in ITA No. 918/Bang/2011, concerning assessment year 2007–08.
The Revenue projected four questions of law. Broadly, it challenged the Tribunal’s reliance on decisions of other Benches for rejecting comparables, its treatment of the TPO’s reasons and its conclusion concerning the arm’s length price of services rendered to associated enterprises.
Want to Read the Complete Judgment?
You have read the free case summary. Unlock the full judgment, the detailed judicial reasoning and the downloadable PDF, along with every other premium judgment on TaxGuru.
Already subscribed? Log in
One subscription covers the entire premium judgment library, not just this case.





